Canada markets closed

Vertex Pharmaceuticals Incorporated (VRTX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
402.14+9.33 (+2.38%)
At close: 04:00PM EDT
406.38 +4.24 (+1.05%)
After hours: 07:48PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 101.52B
Enterprise Value 91.11B
Trailing P/E 28.28
Forward P/E 24.10
PEG Ratio (5 yr expected) 0.53
Price/Sales (ttm)10.37
Price/Book (mrq)5.77
Enterprise Value/Revenue 9.23
Enterprise Value/EBITDA 19.78

Trading Information

Stock Price History

Beta (5Y Monthly) 0.37
52-Week Change 313.41%
S&P500 52-Week Change 323.57%
52 Week High 3448.40
52 Week Low 3320.01
50-Day Moving Average 3410.57
200-Day Moving Average 3383.97

Share Statistics

Avg Vol (3 month) 31.13M
Avg Vol (10 day) 31.02M
Shares Outstanding 5258.46M
Implied Shares Outstanding 6258.46M
Float 8257.56M
% Held by Insiders 10.11%
% Held by Institutions 197.06%
Shares Short (Apr 15, 2024) 44.03M
Short Ratio (Apr 15, 2024) 44.2
Short % of Float (Apr 15, 2024) 41.56%
Short % of Shares Outstanding (Apr 15, 2024) 41.56%
Shares Short (prior month Mar 15, 2024) 44.13M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 22:1
Last Split Date 3Aug 24, 2000

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 36.68%
Operating Margin (ttm)37.97%

Management Effectiveness

Return on Assets (ttm)13.17%
Return on Equity (ttm)22.99%

Income Statement

Revenue (ttm)9.87B
Revenue Per Share (ttm)38.30
Quarterly Revenue Growth (yoy)9.30%
Gross Profit (ttm)N/A
EBITDA 4.48B
Net Income Avi to Common (ttm)3.62B
Diluted EPS (ttm)13.90
Quarterly Earnings Growth (yoy)18.30%

Balance Sheet

Total Cash (mrq)11.22B
Total Cash Per Share (mrq)43.43
Total Debt (mrq)808.4M
Total Debt/Equity (mrq)4.60%
Current Ratio (mrq)3.99
Book Value Per Share (mrq)68.22

Cash Flow Statement

Operating Cash Flow (ttm)3.54B
Levered Free Cash Flow (ttm)3.51B